University of Colorado Health Sciences
Welcome,         Profile    Billing    Logout  
 4 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Burton, James
PROTECT-V, NCT04870333 / 2020-004144-28: PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Recruiting
2/3
5000
Europe
Niclosamide, Placebo, Ciclesonide, Sotrovimab
Cambridge University Hospitals NHS Foundation Trust, Life Arc, Kidney Research UK (KRUK), UNION therapeutics, Addenbrookes Charitable Trust, GlaxoSmithKline, National Institute for Health Research, United Kingdom
Covid19
07/24
12/24
ReliefCensus, NCT05524467: Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients

Completed
N/A
3100
Europe
Vifor (International) Inc.
Chronic Kidney Disease-associated Pruritus
01/24
01/24
PHOSPHATE, NCT03573089: Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease

Recruiting
N/A
3600
Europe, Canada, RoW
Liberal phosphate target, Intensive phosphate target
The University of Queensland, National Health and Medical Research Council, Australia, Applied Health Research Centre, Cambridge University Hospitals NHS Foundation Trust, University of Otago
Kidney Failure, Chronic, Hyperphosphatemia
12/27
12/28
CONFIRM, NCT03586518: Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients

Recruiting
N/A
9
Europe
Cardiac MRI scan, CMR, Echocardiogram, ECHO, Cardiac explantation, 48-Hour continuous cardiac monitoring, Holter, Blood samples
University of Leicester, University Hospitals, Leicester, St George's, University of London
End Stage Kidney Disease, Fibrosis Myocardial
12/24
12/24

Download Options